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Abstract
Background: While gastrointestinal problems are common in ICU patients with multiple organ
failure, gastrointestinal failure has not been given the consideration other organ systems receive.
The aim of this study was to evaluate the incidence of gastrointestinal failure (GIF), to identify its
risk factors, and to determine its association with ICU mortality.
Methods: A retrospective analysis of adult patients (n = 2588) admitted to three different ICUs
(two ICUs at the university hospital Charité-Universitätsmedizin Berlin, Germany and one at Tartu
University Clinics, Estonia) during the year 2002 was performed.
Data recorded in a computerized database were used in Berlin. In Tartu, the data documented in
the patients' charts was retrospectively transferred into a similar database. GIF was defined as
documented gastrointestinal problems (food intolerance, gastrointestinal haemorrhage, and/or
ileus) in the patient data at any period of their ICU stay. ICU mortality, length of stay, and duration
of mechanical ventilation were assessed as outcome parameters.
Results: GIF was identified in 252 patients (9.7% of all patients). Only 20% of GIF patients were
identifiable at admission. GIF was related to significantly higher mortality (43.7% vs. 5.3% in patients
without GIF), as well as prolonged length of ICU stay (10 vs. 2 days) and mechanical ventilation (8
vs. 1 day), p < 0.001, respectively. Patients' profile (emergency surgical or medical), APACHE II and
SOFA scores and the use of catecholamines at admission were identified as independent risk
factors for the development of GIF. Development of GIF during ICU stay was an independent
predictor for death.
Conclusion: Gastrointestinal failure represents a relevant clinical problem accompanied by an
increased mortality, longer ICU stay and mechanical ventilation.
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Background
Patients with multiple organ failure (MOF) are the most
challenging group of patients in modern intensive care.
The gastrointestinal system is one of the clinically impor-
tant systems in MOF, with strong evidence of bacterial
translocation in ICU patients supporting the concept of
the gut being a motor of MOF [1; 2]. On one hand, it has
been suggested that nosocomial infection caused by
enteric bacteria is directly related to the development of
MOF in some patients. On the other hand, this may be a
secondary phenomenon and a symptom rather than a
cause of MOF [3]. The functional status of the gastrointes-
tinal tract has not been studied in full depth and consen-
sus criteria for diagnosis of gastrointestinal failure (GIF)
have not been established. Some authors describe GIF as
"gastroparesis and intestinal ileus" [4], while others
define it as gastrointestinal haemorrhage [5].
None of the scoring systems for organ dysfunction and
severity of illness widely used today take the function of
the gastrointestinal tract into account. The multiple organ
failure (MOF) score, one of the first attempts to quantify
the severity of organ dysfunction and failure, originally
included gastrointestinal tract when it was developed in
1985 [6]. Revision of the score 15 years later however,
concluded that GIF should not be considered in the
assessment of the MOF score due to problems in defini-
tion and reliability [7]. The SOFA score is another well-
established score for assessing organ dysfunction or organ
failure over time, and has proven useful for evaluating
morbidity and predicting ICU mortality [8,9]. The six
organ systems used in calculating this score do not include
GIF. It has not been proven whether an assessment of the
gastrointestinal system would add predictive power to
SOFA estimations of ICU survival. However, recent stud-
ies have shown that intraabdominal hypertension on
admission is associated with severe organ dysfunction
during the ICU stay and the development of intraabdom-
inal hypertension during the ICU stay is an independent
outcome predictor [10].
Despite a large number of human studies suggesting that
the gastrointestinal tract contributes significantly to mor-
bidity and mortality in critically ill ICU patients, data on
risk factors, time-course, prognostic importance, and sug-
gestions for clinical evaluation of gastrointestinal func-
tion are surprisingly poor and inconsistent in existing
literature. The present study was undertaken to identify
the incidence of and independent risk factors for GIF in
ICU patients and to investigate its impact on ICU mortal-
ity.
Methods
A retrospective evaluation of the data of all adult patients
admitted to three different ICUs (two 11-bed ICUs at the
Charité – University Medicine Berlin, Germany and one
10-bed ICU at Tartu University Hospital, Estonia) during
the year 2002 was performed.
In Berlin, the ICUs had a primarily cardiosurgical profile.
The Estonian ICU was a general ICU treating medical and
surgical emergencies, but not cardiosurgical or neurosur-
gical patients. Data recorded in a computerized database
were used for the study in Berlin. In Tartu, the data docu-
mented in the patients' charts was retrospectively trans-
ferred into a similar database. We analysed 47 variables
from first ICU day, including patients' profile (elective
surgical, emergency surgical or medial), age, sex, diagnose
group, source of admission, ICU, APACHE II, SOFA, SAPS
II, mean arterial pressure, heart rate, Glasgow coma scale,
pH, CVP, PEEP, operation time, reoperation, bleeding,
haemoglobin, haematocrit, WBC, platelets, glucose, C-
reactive protein, albumin, protein, bilirubin, creatinine,
urea, pO2/FiO2, lactate, antithrombin III, readmission,
reintubation, mechanical ventilation, use of catecho-
lamines, use of blood products, use of thrombolytics,
sedation, enteral nutrition, renal replacement therapy,
low cardiac output syndrome, renal failure, liver failure,
septic shock, diabetes, reanimation.
Severity of illness was assessed using the Acute Physiology
and Chronic Health Evaluation (APACHE II)score [11] at
admission and Sequential Organ Failure Assessment
(SOFA) [8]score daily.
Group assignment
GIF was defined as the presence of at least one of the fol-
lowing gastrointestinal problems documented in patient
data during their ICU stay: food intolerance, gastrointesti-
nal haemorrhage, and ileus. Food intolerance was defined
as the inability to feed the patient via nasogastric tube due
to vomiting or nasogastric aspirate volumes larger than
those previously given enterally. Gastrointestinal haemor-
rhage was defined as visual presence of blood in nasogas-
tric tube aspirates or in stool. Ileus was defined as
intestinal obstruction due to inhibition of bowel motility.
Prophylactic antacids and prokinetic drugs (metoclopra-
mide) were routinely used in all units.
Ethical approval was obtained at the Charité – University
Medicine Berlin and ethical aspects of the study were con-
sulted with the ethicist of the University of Tartu. Written
informed consent was considered not necessary for the
study, as it is a retrospective analysis of our usual everyday
work. No special interventions were used. All the data
were impersonalised within the respective units before
analysis, and no harm could be weighed against benefit.BMC Gastroenterology 2006, 6:19 http://www.biomedcentral.com/1471-230X/6/19
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Statistics
SPSS (Version 11.5 SPSS Inc., Chicago, IL) software was
used for statistical analysis.
Univariate analysis for comparison of GIF vs. nonGIF
patients was performed using Mann-Whitney U-test for
continuous variables and chi square test for categorical
variables. Analysis of variance (ANOVA) was used for
comparison of groups according to patients' profile.
To identify the risk factors for the development of GIF uni-
variate analyses of parameters recorded on ICU day 1 were
performed using independent samples t-test or Mann-
Whitney U-test for continuous parameters. Chi square
tests were used for categorical variables. Parameters with p
< 0.01 were considered as (univariately) highly predictive
parameters for GIF and were entered into the multiple
logistic regression model. Multiple logistic regression
analysis was performed to identify independent risk fac-
tors for GIF. Stepwise regression was used to ascertain the
most important parameters. Stepwise multiple logistic
regression was also applied to test the severity scores and
GIF as independent risk factors for death.
Results
1. Patients' characteristics
2588 patients were analysed during the study period.
Majority of them (1771 patients) were postoperatively
admitted elective cardiosurgical patients. Among 581
patients hospitalised due to surgical emergency, 310 were
cardiac cases and 271 patients with surgical infections
(pancreatitis, peritonitis, soft tissue infections, etc.) or
traumatic injuries. No isolated neurosurgical patients
were treated during the study period. Among 236 medical
patients 94 patients were resuscitated from cardiac arrest.
Other main reasons for ICU admission of medical
patients were intoxications, pulmonary and infectious
diseases. Mortality of study population was 9.0%, differ-
ing significantly between the groups according to the
patients' profile (2.5% in elective surgical, 19.8% in emer-
gency surgical and 31.4% in medical patients, p < 0.001,
ANOVA).
2. Development and risk factors of GIF
GIF was detected in 252 patients during their ICU stay
(Table 1). The incidence of GIF among patients with sur-
gical and medical emergencies was significantly higher
compared to elective cardiosurgical patients (18.2 % and
19.1 % vs. 5.7% respectively, p < 0.001).
GIF developed late during ICU stay (Figure 1). On admis-
sion only 20% of all GIF cases were seen. 82% of GIF cases
were clinically manifested by the end of the first week in
ICU.
Twenty-three variables listed below, documented at the
day of admission, were identified as highly predictive (p <
0.01) risk factors for GIF development: patients' age, med-
ical profile, haematocrit, leucocyte count, platelet count,
creatinine, urea, bilirubin, C-reactive protein, lactate,
pO2/FiO2, mean arterial pressure, central venous pressure,
APACHE II, SOFA; SAPS II, use of catecholamines, seda-
tion, PEEP, hemodialysis, low-output syndrome, septic
shock, and use of blood products.
In logistic regression analysis we identified the independ-
ent predictors for development of GIF resulting with the
model including:
APACHE II (OR 1.05; 95%CI 1.02–1.09);
SOFA (OR 1.11; 95%CI 1.02–1.20);
patients' emergency profile (OR 3.09; 95%CI 2.11–4.52);
use of catecholamines (OR 4.16; 95%CI 2.82–6.15).
Even though the model allowed us to predict 92.3% from
all of the cases correctly, only 19.8% of GIF (true-positive)
cases could be correctly predicted. True-negative cases, i.e.
nonGIF patients, in contrast, can be correctly predicted in
99.0% of cases.
3. ICU outcome and the risk of death associated with GIF
The development of GIF during the ICU treatment was
associated with a significantly higher mortality, pro-
longed the ICU stay and duration of mechanical ventila-
tion (Table 1). While the overall mortality of this mixed
study population was 9.0 %, the mortality of patients with
GIF was almost eight times of that of nonGIF patients
(43.7% vs. 5.3%, p < 0.001).
Development of GIF during the ICU stay (or its presence
on admission) increased the risk of death markedly in the
overall study population (OR 13.94; 95%CI 10.18–
18.92). In particular, the elective cardiosurgical patients
had tremendously greater likelihood to die if they devel-
oped GIF during the ICU stay (OR 31.82; 95%CI 16.61–
60.95). The risk of death was also significantly increased
for surgical (OR 5.33; 95%CI 3.36–8.46) and medical
emergency patients (OR 13.64; 95%CI 6.22–29.94).
In multiple logistic regression analysis APACHE II and
SOFA scores at admission and development of GIF during
ICU stay were identified as independent risk factors for
death.
The models for prediction of ICU death are described in
Table 2.BMC Gastroenterology 2006, 6:19 http://www.biomedcentral.com/1471-230X/6/19
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Discussion
Table 1: Incidence, characteristics and outcome of gastrointestinal failure (GIF) in intensive care patients. Data are presented as 
medians (with lower and upper quartiles) if not stated otherwise. P-values (Mann-Whitney U-test for continuous variables or chi 
square test for categorical variables) are calculated for the differences between GIF and nonGIF patients
GIF NonGIF Total P-value (GIF vs. 
nonGIF)
Number of patients (% 
from total patients)
252 (9.7%) 2336 (90.3%) 2588 (100.0%)
Female/male ratio; patients 76/176 820/1516 896/1692 0.066
Age; years 67 (60–74) 64 (54–72) 64 (55–72) <0.001
APACHE II score on 
admission; points
18 (14–26) 12 (9–16) 13 (9–17) <0.001
SOFA score on admission; 
points
9 (6–11) 5 (4–7) 5 (4–7) <0.001
Mechanically ventilated; 
patients (%)
226 (89.7%) 1930 (82.6%) 2156 (83.3%) 0.003
Mechanical ventilation; days 8.0 (3.0–19.0) 1.0 (1.0–1.0) 1.0 (1.0–2.0) <0.001
ICU stay; days 10.0 (6.0–23.0) 2.0 (2.0–3.0) 2.0 (2.0–4.0) <0.001
ICU mortality; patients (%) 110 (43.7%) 124 (5.3%) 234 (9,0%) <0.001
Cumulative incidence of gastrointestinal failure during the first week of stay in intensive care Figure 1
Cumulative incidence of gastrointestinal failure during the first week of stay in intensive care.BMC Gastroenterology 2006, 6:19 http://www.biomedcentral.com/1471-230X/6/19
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The present study demonstrates that GIF represents a rele-
vant clinical predictor of mortality in intensive care
patients. GIF significantly prolonged mechanical ventila-
tion and ICU stay. This study suggests the need for further
investigation and discussion in order to develop a proper
clinical definition and an evaluation system for gastroin-
testinal failure.
GIF was observed less frequently in patients following
elective cardiac surgery. Indeed, patients admitted for sur-
gical or medical emergencies developed gastrointestinal
problems much more frequently and often presented with
these symptoms on admission. However, regardless of
ICU location or patient profile, the analysis consistently
revealed that development of GIF during patients' ICU
treatment resulted in a significant increase in the duration
of mechanical ventilation, length of stay and, most impor-
tantly, of ICU mortality. The overall mortality (GIF and
nonGIF) in elective cardiosurgical patients was 2.5 %,
while in patients without GIF it was very low – only 1.1%.
By contrast, the influence of GIF development on mortal-
ity was tremendous: the risk of death showed a twenty-
three-fold increase. This is in accordance with recent anal-
ysis of cardiac surgery patients demonstrating that devel-
opment of postoperative organ failures (respiratory
failure, acute renal failure) significantly prolongs the ICU
stay and is associated with lower survival [12]. The impor-
tance of gastrointestinal function in cardiosurgical
patients has been addressed in other recent studies. Hessel
demonstrated, that gastrointestinal complications occur
in about 2.5% of patients undergoing cardiac surgery and
that the occurrence of these complications is associated
with a high mortality [13]. Ishikawa et al. described simi-
lar results [14].
In our study, the risk of death was significantly increased
also among emergency surgical and medical patients with
GIF. One possible tool for the assessment of GI function,
measurement of intraabdominal pressure, was not per-
formed in our patients. In recent studies, intraabdominal
hypertension has been associated with worse outcome in
mixed critically ill patients [10]. Still, it needs to be clari-
fied, whether the measurement of intra-abdominal pres-
sure alone is sufficient for complex assessment of GI
function [15].
The impact of GIF on ICU mortality and length of stay
clearly points out the need for predictors for GIF using
patient characteristics on the day of admission. Identify-
ing the population at risk would clearly be beneficial,
allowing the practitioner to apply necessary strategies to
prevent the development of the syndrome. Even though
we identified several highly predictive parameters and
four independent predictors for GIF development, the
attempts to develop an equation correctly predicting the
manifestation of GIF were not successful. There are several
explanations for this. One involves the categorisation of
patients according to the presence or absence of GIF. It is
obvious that organ failure is not an all-or-nothing phe-
nomenon, but a progression of alterations from normal
organ function to organ failure [16]. GIF is a syndrome
with a variable onset during ICU treatment. In their origi-
nal study introducing the MOF score, Goris et al. noticed
that the mean onset of GI failure was on the 23rd ICU day
in severe trauma patients and on the 11th day in patients
with septic intra-abdominal complications following sur-
gery [6]. GIF was defined as cholecystitis, stress ulcer, GI
haemorrhage, necrotic enterocolitis or pancreatitis and/or
spontaneous perforation of the gallbladder. In the present
study, 80% of GIF patients were identifiable by the end of
the 1st week of stay in the ICU, while 20% developed GIF
later. Length of stay in the ICU was significantly longer in
GIF patients compared to non-GIF patients. All these
results indicate that development of GIF may occur late in
a patients' ICU stay. This could prove to be one of the
main problems in GIF prediction based on patient data at
admission. It is possible that not the variables at admis-
sion, but changes in these characteristics following the
Table 2: Logistic regression models for prediction of death in whole study population and in different groups according to patients' 
profile
Total Elective surgical Emergency surgical Medical
Predictors p-value
OR (95% CI)
p-value
OR (95% CI)
p-value
OR (95% CI)
p-value 
OR(95% CI)
APACHE II 0.020
1.03 (1.01–1.06)
0.031
1.06 (1.01–1.13)
0.730
1.01 (0.97–1.04)
0.259
1.03 (0.98–1.09)
SOFA <0.001
1.35 (1.27–1.44)
0.013
1.20 (1.04–1.39)
<0.001
1.30 (1.20–1.41)
<0.001
1.36 (1.19–1.55)
GIF <0.001
7.44 (5.21–10.62)
<0.001
15.42 (7.67–31.04)
<0.001
3.31 (1.97–5.55)
<0.001
7.43 (3.00–18.36)
Pseudo R-square 
Nagelkerke's coeff.
0.40 0.35 0.33 0.56BMC Gastroenterology 2006, 6:19 http://www.biomedcentral.com/1471-230X/6/19
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first day of treatment, could prove more reliable for pre-
diction of GIF.
In the opinion of the authors, the absence of a consensus
definition of GIF is a major limiting factor of research on
the area. The absence of a clear definition of GIF and the
retrospective design should also be considered as main
limitations of present study. The symptoms used for the
diagnosis of GIF were somewhat vaguely specified and
that may interfere with the results. Further, the severity of
the GI symptoms was not accounted – for example, food
intolerance and gastrointestinal haemorrhage were
weighted uniformly. While definitions and grading based
on defined clinical signs and laboratory findings are avail-
able for most organ failures – for example, ARDS and ALI
in respiratory failure, NYHA classes in heart failure, renal
dysfunction and failure – a well-accepted definition of
gastrointestinal failure is absent. It has been suggested
that the assessment of gastrointestinal function, being
subjective and hardly measurable, would have negligible
impact on the scoring of organ functions for subsequent
prediction of ICU performance [7]. In the present study
development of GIF during ICU stay was identified as an
independent risk factor for death. However, it should be
considered that GIF was mostly not present at admission
but developed during the entire ICU period, while the
other risk factors in our model: APACHE II and SOFA;
were documented on day 1. Also it should be considered
that APACHE II was originally validated for hospital mor-
tality [11] while ICU mortality was assessed in our study.
These facts are probably diminishing the practical value of
our model for prediction of death.
The profile of patients studied should also be carefully
considered – most of the patients were elective cardiosur-
gical patients. In our study, low output syndrome was a
highly predictive parameter and the use of catecholamines
an independent risk factor for GIF. This fact is probably
appointing GIF development being associated with global
hypoperfusion in patients with compromised cardiovas-
cular system. The deteriorated gastrointestinal barrier
function after cardiopulmonary bypass may also contrib-
ute to the development of GIF in cardiac surgery patients
[17]. Cardiovascular SOFA category was not assessed sep-
arately in our analysis due to missing respective data, but
might be of value in further studies, especially in cardio-
surgical patients.
Conclusion
GIF should be considered a relevant clinical predictor of
increased mortality and prolonged ICU stay. Several risk
factors for the development of GIF could be identified.
The most dramatic risk of death was observed in elective
cardiac surgery patients. However, predicting GIF remains
still very complicated. Further studies, defining the syn-
drome of gastrointestinal failure and investigating its
impact on ICU patients are warranted.
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